These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34507064)

  • 1. Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells.
    Wang Z; Qu K; Zhou L; Ren L; Ren B; Meng F; Yu W; Wang H; Fan H
    Biochem Biophys Res Commun; 2021 Nov; 577():45-51. PubMed ID: 34507064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharide from Lentinus edodes combined with oxaliplatin possesses the synergy and attenuation effect in hepatocellular carcinoma.
    Zhang Y; Li Q; Wang J; Cheng F; Huang X; Cheng Y; Wang K
    Cancer Lett; 2016 Jul; 377(2):117-25. PubMed ID: 27130669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose.
    Takemura A; Che XF; Tabuchi T; Moriya S; Miyazawa K; Tomoda A
    Oncol Rep; 2012 Feb; 27(2):347-55. PubMed ID: 22076586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage.
    Tan J; Song M; Zhou M; Hu Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):17-23. PubMed ID: 28069382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lentinan combined with docetaxel and cisplatin on the proliferation and apoptosis of BGC823 cells.
    Zhao L; Xiao Y; Xiao N
    Tumour Biol; 2013 Jun; 34(3):1531-6. PubMed ID: 23404406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines.
    Henrici A; Montalbano R; Neureiter D; Krause M; Stiewe T; Slater EP; Quint K; Ocker M; Di Fazio P
    Mol Carcinog; 2015 Aug; 54(8):585-97. PubMed ID: 24375802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
    Ou Y; Zhai D; Wu N; Li X
    Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
    Chen C; Ai QD; Wei YH
    J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apaf1 inhibition promotes cell recovery from apoptosis.
    Gortat A; Sancho M; Mondragón L; Messeguer À; Pérez-Payá E; Orzáez M
    Protein Cell; 2015 Nov; 6(11):833-43. PubMed ID: 26361785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.
    Lau CK; Yang ZF; Lam SP; Lam CT; Ngai P; Tam KH; Poon RT; Fan ST
    Cancer Biol Ther; 2007 Dec; 6(12):1900-7. PubMed ID: 18059167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2.
    Qu X; Gao H; Zhai J; Sun J; Tao L; Zhang Y; Song Y; Hu T
    Eur J Pharm Sci; 2020 May; 148():105325. PubMed ID: 32259679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.
    Xu Y; An Y; Wang Y; Zhang C; Zhang H; Huang C; Jiang H; Wang X; Li X
    Oncol Rep; 2013 May; 29(5):2019-24. PubMed ID: 23483142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma.
    Qiao G; Xu H; Li C; Li X; Farooqi AA; Zhao Y; Liu X; Liu M; Stagos D; Lin X
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells.
    Fan L; Song B; Sun G; Ma T; Zhong F; Wei W
    PLoS One; 2013; 8(5):e62627. PubMed ID: 23658755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis.
    Liu FY; Wu YH; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Huang ZY
    Oncol Rep; 2014 Aug; 32(2):835-44. PubMed ID: 24919588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
    El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
    Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.